Skip to content

Apyx Medical Corporation APYX Surgical Aesthetics — Profit Loss

Similar metrics at other companies

Bausch + Lomb logo
BLCOSurgical — Operating Income (Loss)
$9M+229%
IAR
IARTSpecialty Surgery — Operating Income (Loss)
$83.13M+15.1%
Surgery Partners, Inc. logo
SGRYSurgical Facilities — Income (loss) before income taxes
-$3.3M-1,000%
Journey Medical Corporation logo
DERMDermatological — Net Income Loss
-$2.23M+45.2%
Helen Of Troy logo
HELEBeauty & Wellness — Operating Income (Loss)
-$67.66M
The Marygold Companies logo
MGLDBeauty Products — Operating Income
-$54K+57.5%

Other financials

Income statement

See full
Revenue$12.5M+32.4%
Gross profit$7.5M-19.2%
Operating income-$5.5M-349%
Net income-$2.1M+48.6%
EPS (diluted)-$0.19-533%

Balance sheet

See full
Cash & equivalents$31.1M+0.4%
Total debt$39.5M+1.4%
Total equity$12.8M+22.1%
Total assets$63.0M+4.8%

Cash flow

See full
Operating cash flow-$572.0K+18.5%
CapEx$60.0K+9.1%
Free cash flow-$632.0K+16.5%

Valuation

See full
Market cap$181.07M+114%
Enterprise value$189.4M+101%
P/S3.2×+1.4×

Profitability

See full
Gross margin61.9%-3.1pp
Operating margin-46%+9.9pp
Net margin-16.2%-6.2pp
FCF margin-16.1%-4.8pp

Returns & leverage

See full
Return on equity-77.8%-22.4pp
Debt / equity3.1×-0.6×
Current ratio5.8×+0.3×

Where this comes from

Reported directly by Apyx Medical Corporation in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The official record: Apyx Medical Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apyx Medical Corporation's surgical aesthetics — profit loss.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Apyx Medical Corporation's surgical aesthetics — profit loss?
Apyx Medical Corporation (APYX) reported surgical aesthetics — profit loss of $1.99M in Q1 2026.
What does surgical aesthetics — profit loss mean?
This metric measures the net operating profit or loss generated by the Surgical Aesthetics business segment after accounting for direct revenues and associated operating expenses. It serves as a primary indicator of the segment's standalone financial viability and its contribution to the overall corporate bottom line. Analyzing this figure helps stakeholders evaluate the profitability trends and operational efficiency of the company's aesthetic product portfolio.